Below are Top Highlights for November 2014: (Please click on read more to see details)
- Temasek, Singapore enters India market by acquiring 10.16% stake in Intas Pharma, India
- Aurobindo Pharma to buy Natrol for $132.5 million Read more
- J&J acquires ORSL electrolyte drink brand from Jagdale Industries, in a deal estimated by industry experts at USD 125 Million.
- Cipla’s Europe Subsidiary signs distribution agreement with Serum Institute India for Paediatric Vaccines in Europe Read more
- India’s Cipla & Strides Arcolab collaborate with Medicines for Malaria Venture (MVV); Project funded by UNITAID Read more
- Biocon, India expands partnership with US firm CytoSorbents for critical care drugRead more
- InVentis India and TriLink BioTechnologies Inc, US enter into distribution agreement.Readmore
- India, UK sign agreements, creation of joint £100 million Newton-Babha fund announced
- Venus Remedies, India set to launch its Meropenem drug in Switzerland though Europe Partner Swiss Pharma GmbH
- Vanta Bioscience of India to be acquired by GVK BIO
- India’s Transasia named ‘Global Growth Company 2014' by World Economic Forum
Aagami Updates: (Please click on hyperlink to view details)
- Aagami's latest Company Presentation and Case Studies are available on its company website.
- Deals closing trip to India by Aagami CEO Dinesh Jain Read more
- Aagami to participate in JP Morgan Healthcare and BioTech Showcase 2015 Read more